Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
doi:10.1001/jama.2023.24539 45
Effect of Combination Therapy on Metabolic Outcomes Based on a 2019 meta-analysis of seven randomised controlled trials (1,913 participants) with a primary duration ranging from 12 to 30 weeks, co-administration of SGLT-2 inhibitors and GLP-1 receptor agonists had a less than additive effect on HbA 1c and body weight and an additive reduction in systolic blood pressure compared with each monocomponent without increasing risk of hypoglycaemia [5]
V., Javadov, S., & Sommer, N
190 6.3 mg dl 1 vs
US$ 21.75
US$ 23.92
US$ 24.90
US$ 28.11
US$ 29.23
